H.R. 9830

Lawful Hemp Protection Act

7 cosponsors

Where it stands

Introduced Jul 22
Committee Now
House of Representatives —
Senate —
Law —

Introduced Jul 22
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Jul 22)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

Expand all

Sec. 1. Short title

Sec. 2. Findings

Sec. 3. Definition of hemp

Sec. 4. FDA oversight and milligram limitations

Sec. 5. Allowing coverage of hemp-derived cannabinoid products under Medicare Advantage as a special supplemental benefit for the chronically ill; codifying substance access beneficiary engagement incentive

Sec. 6. Taxes on hemp-derived cannabinoid products and related requirements

Sec. 7. Unfair competition and unlawful practices

Sec. 8. Prohibition related to unfinished hemp-cannabinoid ingredients

Sec. 9. Zero tolerance for impaired driving

Sec. 10. Protection of State regulatory authority and interstate commerce

Sec. 11. Severability

If any provision of this Act or the amendments made by this Act, or the application of any such provision to any person or circumstance, is held to be unconstitutional or otherwise invalid by a court of competent jurisdiction, the remainder of this Act and the amendments made by this Act, and the application of the provisions of this Act and the amendments made by this Act to any other person or circumstance, shall not be affected thereby.